ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025
ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025 GlobeNewswire November 07, 2025 The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green CNS (Vafidemstat) Received feedback from the FDA on Phase III PORTICO-2 trial in […]